BIOMAT Database Logo BIOMAT Database Logo

Synthesis and potent anti-HIV activity of L-2',3'-didehydro-2',3'-dideoxy-2'-fluoro-4'-thiocytidine. 2002

Yongseok Choi, and Hyunah Choo, and Youhoon Chong, and Sookwang Lee, and Sureyya Olgen, and Raymond F Schinazi, and Chung K Chu
Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, The University of Georgia, Athens, Georgia 30602, USA.

[reaction: see text] L-2'-Fluoro-4'-thio-2',3'-unsaturated cytidine 11 was synthesized from (R)-2-fluorobutenolide 2, which was prepared from 2,3-O-isopropylidene-L-glyceraldehyde 1. The synthesized compound 11 shows potent antiviral activity against HIV-1.

UI MeSH Term Description Entries
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003562 Cytidine A pyrimidine nucleoside that is composed of the base CYTOSINE linked to the five-carbon sugar D-RIBOSE. Cytosine Ribonucleoside,Cytosine Riboside,Ribonucleoside, Cytosine,Riboside, Cytosine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013872 Thionucleosides Nucleosides in which the base moiety is substituted with one or more sulfur atoms.
D015224 Dideoxynucleosides Nucleosides that have two hydroxy groups removed from the sugar moiety. The majority of these compounds have broad-spectrum antiretroviral activity due to their action as antimetabolites. The nucleosides are phosphorylated intracellularly to their 5'-triphosphates and act as chain-terminating inhibitors of viral reverse transcription. 2',3'-Dideoxynucleosides,Dideoxyribonucleosides,ddNus,2',3' Dideoxynucleosides
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV
D020128 Inhibitory Concentration 50 The concentration of a compound needed to reduce population growth of organisms, including eukaryotic cells, by 50% in vitro. Though often expressed to denote in vitro antibacterial activity, it is also used as a benchmark for cytotoxicity to eukaryotic cells in culture. IC50,Concentration 50, Inhibitory

Related Publications

Yongseok Choi, and Hyunah Choo, and Youhoon Chong, and Sookwang Lee, and Sureyya Olgen, and Raymond F Schinazi, and Chung K Chu
D- and L-2',3'-didehydro-2',3'-dideoxy-3'-fluoro-carbocyclic nucleosides: synthesis, anti-HIV activity and mechanism of resistance.
April 2007, Journal of medicinal chemistry,
Yongseok Choi, and Hyunah Choo, and Youhoon Chong, and Sookwang Lee, and Sureyya Olgen, and Raymond F Schinazi, and Chung K Chu
Synthesis of 3'-fluoro-2',3'-dideoxy-2',3'-didehydro-4'-ethynyl-D- and -L-furanosyl nucleosides.
September 2004, The Journal of organic chemistry,
Yongseok Choi, and Hyunah Choo, and Youhoon Chong, and Sookwang Lee, and Sureyya Olgen, and Raymond F Schinazi, and Chung K Chu
Synthesis and potent anti-HIV activity of L-3'-fluoro-2',3'-unsaturated cytidine.
December 2001, Organic letters,
Yongseok Choi, and Hyunah Choo, and Youhoon Chong, and Sookwang Lee, and Sureyya Olgen, and Raymond F Schinazi, and Chung K Chu
l-2',3'-Didehydro-2',3'-dideoxy-3'-fluoronucleosides: synthesis, anti-HIV activity, chemical and enzymatic stability, and mechanism of resistance.
July 2003, Journal of medicinal chemistry,
Yongseok Choi, and Hyunah Choo, and Youhoon Chong, and Sookwang Lee, and Sureyya Olgen, and Raymond F Schinazi, and Chung K Chu
Synthesis and anti-HIV activity of L-2',3'-Dideoxy-4'-selenonucleosides (L-4'-Se-ddNs).
September 2019, Archives of pharmacal research,
Yongseok Choi, and Hyunah Choo, and Youhoon Chong, and Sookwang Lee, and Sureyya Olgen, and Raymond F Schinazi, and Chung K Chu
Synthesis and anti-HIV activity of carbocyclic 2',3'-didehydro-2',3'-dideoxy 2,6-disubstituted purine nucleosides.
January 1990, Journal of medicinal chemistry,
Yongseok Choi, and Hyunah Choo, and Youhoon Chong, and Sookwang Lee, and Sureyya Olgen, and Raymond F Schinazi, and Chung K Chu
5'-O-ester prodrugs of potent and selective anti-HIV agent--2',3'-dideoxy-3'-fluoro-2-thiothymidine (S2FLT): synthesis and anti-HIV activity.
January 2003, Nucleosides, nucleotides & nucleic acids,
Yongseok Choi, and Hyunah Choo, and Youhoon Chong, and Sookwang Lee, and Sureyya Olgen, and Raymond F Schinazi, and Chung K Chu
Stereoselective synthesis of beta-L-2',3'-dideoxy- and L-2',3'-didehydro-2',3'-dideoxy purine nucleosides.
January 1999, Nucleosides & nucleotides,
Yongseok Choi, and Hyunah Choo, and Youhoon Chong, and Sookwang Lee, and Sureyya Olgen, and Raymond F Schinazi, and Chung K Chu
Synthesis and anti-HIV activity of 4'-cyano-2',3'-didehydro-3'-deoxythymidine.
January 2004, Nucleosides, nucleotides & nucleic acids,
Yongseok Choi, and Hyunah Choo, and Youhoon Chong, and Sookwang Lee, and Sureyya Olgen, and Raymond F Schinazi, and Chung K Chu
Asymmetric synthesis and anti-HIV activity of L-carbocyclic 2',3'-didehydro-2',3'-dideoxyadenosine.
July 1998, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!